Form 4: Enovix Director McCranie Receives RSU Grant

Director J. Daniel McCranie was granted 29,104 restricted stock units as part of his compensation package.

Summary

• Director J. Daniel McCranie acquired 29,104 restricted stock units (RSUs) of Enovix Corporation common stock.
• The transaction occurred on June 11, 2026, at a price of $0 per share as part of an equity grant.
• Following this transaction, the director's total beneficial ownership increased to 69,982 shares.
• The RSUs are subject to a vesting schedule spanning from September 2026 through June 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine director compensation.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified; this is a standard compensatory equity grant.

Risks

• Vesting is contingent upon the director's continuous service to the company.

Future Outlook

The RSUs will vest in four equal installments on September 11, 2026, December 11, 2026, March 11, 2027, and June 11, 2027, subject to continued service.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice in the technology and battery manufacturing sectors to ensure board alignment with company performance.

Comparison to Industry Standards

• The use of RSU-based compensation for board members is consistent with standard practices for publicly traded companies in the U.S. technology sector.
• Vesting schedules tied to annual meeting cycles are common among peer companies to ensure board continuity.

Stakeholder Impact

• Minimal impact on shareholders; reflects standard director compensation practices.

Next Steps

• Vesting of the first tranche of RSUs on September 11, 2026.

Key Dates

Keywords

Enovix, ENVX, Form 4, Insider Trading, Director Compensation, Restricted Stock Units